The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Infectious Disease Diagnostics Market Research Report 2024

Global Infectious Disease Diagnostics Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1885486

No of Pages : 102

Ask Your Query

Synopsis

Infectious disease diagnostics are medical tests and assays used to identify infectious agents, such as bacteria, viruses, and parasites, in patient samples. They play a crucial role in early detection and effective management of infectious diseases.

The global Infectious Disease Diagnostics market was valued at US$ 3644 million in 2023 and is anticipated to reach US$ 4776.2 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.

The market for infectious disease diagnostics is driven by the increasing prevalence of infectious diseases and the need for accurate and rapid diagnostic solutions to control disease outbreaks. The market's growth is also influenced by technological advancements, such as molecular diagnostics and point-of-care testing.

This report aims to provide a comprehensive presentation of the global market for Infectious Disease Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Diagnostics.

Report Scope

The Infectious Disease Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Infectious Disease Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.


By Company (Partial List):

  • Bio Mérieux SA
  • Roche Diagnostics
  • Abbott Laboratories
  • Thermo Fischer Scientific
  • BD
  • Bio-Rad Laboratories
  • Abbott
  • Danaher
  • Johnson and Johnson
  • Guangzhou Wondfo Biotech Co.,Ltd.
  • Getein Biotech, Inc.
  • Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
  • BGI Genomics Co.,Ltd.
  • Maccura Biotechnology Co.,Ltd.
  • Daan Gene
  • Beijing Strong Biotechnologies,Inc
  • Shanghai Kehua Bio-Engineering Co.,Ltd.
  • Guangdong Hybribio Biotech Co.,Ltd.
  • Shanghai Runda Medical Technology Co.,Ltd.
  • Tellgen Corporation

Segment by Type

  • Molecular Diagnostic Technique
  • Traditional Diagnostic Technique

Segment by Application

  • Hepatitis C
  • Hepatitis B
  • Tuberculosis (TB)
  • Acquired Immunodeficiency Syndrome (AIDS)
  • Human Papillomavirus (HPV)
  • Methicillin-resistant Staphylococcus Aureus (MRSA)

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Molecular Diagnostic Technique
1.2.3 Traditional Diagnostic Technique
1.3 Market by Application
1.3.1 Global Infectious Disease Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hepatitis C
1.3.3 Hepatitis B
1.3.4 Tuberculosis (TB)
1.3.5 Acquired Immunodeficiency Syndrome (AIDS)
1.3.6 Human Papillomavirus (HPV)
1.3.7 Methicillin-resistant Staphylococcus Aureus (MRSA)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Diagnostics Market Perspective (2019-2030)
2.2 Infectious Disease Diagnostics Growth Trends by Region
2.2.1 Global Infectious Disease Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Disease Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Infectious Disease Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Infectious Disease Diagnostics Market Dynamics
2.3.1 Infectious Disease Diagnostics Industry Trends
2.3.2 Infectious Disease Diagnostics Market Drivers
2.3.3 Infectious Disease Diagnostics Market Challenges
2.3.4 Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Diagnostics Players by Revenue
3.1.1 Global Top Infectious Disease Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Infectious Disease Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Diagnostics Revenue
3.4 Global Infectious Disease Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostics Revenue in 2023
3.5 Infectious Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Infectious Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Infectious Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Diagnostics Breakdown Data by Type
4.1 Global Infectious Disease Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Infectious Disease Diagnostics Forecasted Market Size by Type (2025-2030)
5 Infectious Disease Diagnostics Breakdown Data by Application
5.1 Global Infectious Disease Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Infectious Disease Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Disease Diagnostics Market Size (2019-2030)
6.2 North America Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infectious Disease Diagnostics Market Size by Country (2019-2024)
6.4 North America Infectious Disease Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Diagnostics Market Size (2019-2030)
7.2 Europe Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infectious Disease Diagnostics Market Size by Country (2019-2024)
7.4 Europe Infectious Disease Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Infectious Disease Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infectious Disease Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Infectious Disease Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Diagnostics Market Size (2019-2030)
9.2 Latin America Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infectious Disease Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Infectious Disease Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Infectious Disease Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infectious Disease Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Infectious Disease Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio Mérieux SA
11.1.1 Bio Mérieux SA Company Detail
11.1.2 Bio Mérieux SA Business Overview
11.1.3 Bio Mérieux SA Infectious Disease Diagnostics Introduction
11.1.4 Bio Mérieux SA Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.1.5 Bio Mérieux SA Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Detail
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Infectious Disease Diagnostics Introduction
11.2.4 Roche Diagnostics Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.2.5 Roche Diagnostics Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Infectious Disease Diagnostics Introduction
11.3.4 Abbott Laboratories Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 Thermo Fischer Scientific
11.4.1 Thermo Fischer Scientific Company Detail
11.4.2 Thermo Fischer Scientific Business Overview
11.4.3 Thermo Fischer Scientific Infectious Disease Diagnostics Introduction
11.4.4 Thermo Fischer Scientific Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.4.5 Thermo Fischer Scientific Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD Infectious Disease Diagnostics Introduction
11.5.4 BD Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.5.5 BD Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Infectious Disease Diagnostics Introduction
11.6.4 Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Infectious Disease Diagnostics Introduction
11.7.4 Abbott Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.7.5 Abbott Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher Infectious Disease Diagnostics Introduction
11.8.4 Danaher Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.8.5 Danaher Recent Development
11.9 Johnson and Johnson
11.9.1 Johnson and Johnson Company Detail
11.9.2 Johnson and Johnson Business Overview
11.9.3 Johnson and Johnson Infectious Disease Diagnostics Introduction
11.9.4 Johnson and Johnson Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.9.5 Johnson and Johnson Recent Development
11.10 Guangzhou Wondfo Biotech Co.,Ltd.
11.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Detail
11.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Business Overview
11.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Infectious Disease Diagnostics Introduction
11.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Development
11.11 Getein Biotech, Inc.
11.11.1 Getein Biotech, Inc. Company Detail
11.11.2 Getein Biotech, Inc. Business Overview
11.11.3 Getein Biotech, Inc. Infectious Disease Diagnostics Introduction
11.11.4 Getein Biotech, Inc. Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.11.5 Getein Biotech, Inc. Recent Development
11.12 Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
11.12.1 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Company Detail
11.12.2 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Business Overview
11.12.3 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Infectious Disease Diagnostics Introduction
11.12.4 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.12.5 Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Recent Development
11.13 BGI Genomics Co.,Ltd.
11.13.1 BGI Genomics Co.,Ltd. Company Detail
11.13.2 BGI Genomics Co.,Ltd. Business Overview
11.13.3 BGI Genomics Co.,Ltd. Infectious Disease Diagnostics Introduction
11.13.4 BGI Genomics Co.,Ltd. Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.13.5 BGI Genomics Co.,Ltd. Recent Development
11.14 Maccura Biotechnology Co.,Ltd.
11.14.1 Maccura Biotechnology Co.,Ltd. Company Detail
11.14.2 Maccura Biotechnology Co.,Ltd. Business Overview
11.14.3 Maccura Biotechnology Co.,Ltd. Infectious Disease Diagnostics Introduction
11.14.4 Maccura Biotechnology Co.,Ltd. Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.14.5 Maccura Biotechnology Co.,Ltd. Recent Development
11.15 Daan Gene
11.15.1 Daan Gene Company Detail
11.15.2 Daan Gene Business Overview
11.15.3 Daan Gene Infectious Disease Diagnostics Introduction
11.15.4 Daan Gene Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.15.5 Daan Gene Recent Development
11.16 Beijing Strong Biotechnologies,Inc
11.16.1 Beijing Strong Biotechnologies,Inc Company Detail
11.16.2 Beijing Strong Biotechnologies,Inc Business Overview
11.16.3 Beijing Strong Biotechnologies,Inc Infectious Disease Diagnostics Introduction
11.16.4 Beijing Strong Biotechnologies,Inc Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.16.5 Beijing Strong Biotechnologies,Inc Recent Development
11.17 Shanghai Kehua Bio-Engineering Co.,Ltd.
11.17.1 Shanghai Kehua Bio-Engineering Co.,Ltd. Company Detail
11.17.2 Shanghai Kehua Bio-Engineering Co.,Ltd. Business Overview
11.17.3 Shanghai Kehua Bio-Engineering Co.,Ltd. Infectious Disease Diagnostics Introduction
11.17.4 Shanghai Kehua Bio-Engineering Co.,Ltd. Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.17.5 Shanghai Kehua Bio-Engineering Co.,Ltd. Recent Development
11.18 Guangdong Hybribio Biotech Co.,Ltd.
11.18.1 Guangdong Hybribio Biotech Co.,Ltd. Company Detail
11.18.2 Guangdong Hybribio Biotech Co.,Ltd. Business Overview
11.18.3 Guangdong Hybribio Biotech Co.,Ltd. Infectious Disease Diagnostics Introduction
11.18.4 Guangdong Hybribio Biotech Co.,Ltd. Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.18.5 Guangdong Hybribio Biotech Co.,Ltd. Recent Development
11.19 Shanghai Runda Medical Technology Co.,Ltd.
11.19.1 Shanghai Runda Medical Technology Co.,Ltd. Company Detail
11.19.2 Shanghai Runda Medical Technology Co.,Ltd. Business Overview
11.19.3 Shanghai Runda Medical Technology Co.,Ltd. Infectious Disease Diagnostics Introduction
11.19.4 Shanghai Runda Medical Technology Co.,Ltd. Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.19.5 Shanghai Runda Medical Technology Co.,Ltd. Recent Development
11.20 Tellgen Corporation
11.20.1 Tellgen Corporation Company Detail
11.20.2 Tellgen Corporation Business Overview
11.20.3 Tellgen Corporation Infectious Disease Diagnostics Introduction
11.20.4 Tellgen Corporation Revenue in Infectious Disease Diagnostics Business (2019-2024)
11.20.5 Tellgen Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock